Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day
DuPont is now marketing Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day.
Sustiva is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...in the same class as Rescriptor and Viramune.
It seems to be as potent as a protease inhibitor...when added to nucleoside inhibitors such as Retrovir and 3TC.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote